Impact of COVID-19 pandemic on mortality rate in memory clinic patients

Els D Bakker1,2, Ingrid S van Maurik1,2,3,4,5, Marissa D Zwan1,2

  • 1Alzheimer Center Amsterdam, Neurology Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc Amsterdam The Netherlands.

Insights

Mortality risk increased for memory clinic patients during the COVID-19 pandemic, particularly for those with dementia. This excess mortality was primarily linked to coronavirus disease 2019 infections.

Area of Science:

  • Neurology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic significantly impacted global health, necessitating investigations into its effects on vulnerable populations.
  • Memory clinics serve diverse patient groups, including those with cognitive impairments, making them a key focus for assessing pandemic-related mortality.
  • Understanding mortality trends in memory clinic attendees is crucial for public health preparedness and clinical management.

Purpose of the Study:

  • To determine if mortality rates changed in memory clinic patients during the COVID-19 pandemic compared to a pre-pandemic historical control group.
  • To identify specific patient subgroups within memory clinics who experienced altered mortality risks during the pandemic.
  • To ascertain the primary causes of death contributing to any observed changes in mortality.

Main Methods:

  • A cohort study design was employed, comparing 923 patients from the Amsterdam Dementia Cohort during the pandemic (2017-2021) with 830 historical control patients (2015-2019).
  • Patients included individuals across the cognitive spectrum: subjective cognitive decline (SCD), mild cognitive impairment (MCI), and dementia.
  • Cox regression analysis was used to compare mortality rates, with Fisher's exact test examining differences in causes of death.

Main Results:

  • Memory clinic patients during the pandemic exhibited a significantly higher mortality risk (HR: 1.34; 95% CI: 1.05-1.70) compared to historical controls.
  • This increased risk was particularly pronounced and remained significant in patients diagnosed with dementia (HR: 1.35; 95% CI: 1.03-1.78).
  • Excluding deaths due to COVID-19 infection attenuated the overall increased mortality risk (HR: 1.24; 95% CI: 0.97-1.58), highlighting COVID-19 as a major contributing factor (p=0.001).

Conclusions:

  • Memory clinic patients faced an elevated risk of mortality during the COVID-19 pandemic.
  • The increased mortality was significantly attributable to patients with dementia.
  • Deaths directly resulting from COVID-19 infection were the primary driver of the excess mortality observed in this cohort.
Abstract

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
573
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
225
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
48
Hospitals-I01:28

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
847